Chaouki A Sami, Spar David S, Khoury Philip R, Anderson Jeffrey B, Knilans Timothy K, Morales David L S, Czosek Richard J
Division of Cardiology, Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Division of Cardiology, Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Heart Rhythm. 2017 Feb;14(2):206-210. doi: 10.1016/j.hrthm.2016.10.017. Epub 2016 Oct 15.
Complications related to epicardial pacemakers in infants have been reported, though limited data are available on their incidence and associated risk factors.
The hypothesis of the study is that younger, smaller patients and larger devices would be associated with complications in neonates and infants.
This is a retrospective study of all patients at a single center receiving an epicardial pacemaker at ≤12 months of age (1996-2015). Patient and device characteristics were obtained. Characteristics of patients with and without complications were compared.
There were 86 patients with a median age of 73 days (interquartile range 13-166 days), of whom 12 (14%) had a complication. Eight (9%) needed surgical intervention, of whom 5 (6%) required explantation. Younger age (9 days vs 89 days; P = .01) and lower weight (2.91 kg vs 4.44 kg; P = .004) at implantation were associated with complications. Device characteristics were not statistically different. Patients ≤3 kg in weight and/or <5 days of age had an odds ratio of 18.1 (3.6-91.2; P < .001) for developing a complication with a negative predictive value (NPV) of 97%. Regardless of weight, patients aged >21 days were found to be at lower risk with an NPV of 96%; and regardless of age, patients weighing >4 kg had an NPV of 98%.
Young age and low weight at the time of implantation are risk factors for complications, while device characteristics appear to play a minor role. Reserving pacemaker implantation for patients >3 kg in weight and 5 days of age may predict patients at low risk of developing complications.
虽然关于婴儿心外膜起搏器相关并发症的发生率及相关危险因素的数据有限,但已有相关报道。
本研究的假设是年龄更小、体重更轻的患者以及更大的设备与新生儿和婴儿的并发症相关。
这是一项对单一中心1996 - 2015年期间年龄≤12个月接受心外膜起搏器治疗的所有患者的回顾性研究。获取了患者和设备的特征。比较了有并发症和无并发症患者的特征。
共有86例患者,中位年龄73天(四分位间距13 - 166天),其中12例(14%)出现并发症。8例(9%)需要手术干预,其中5例(6%)需要取出起搏器。植入时年龄较小(9天对89天;P = 0.01)和体重较低(2.91 kg对4.44 kg;P = 0.004)与并发症相关。设备特征无统计学差异。体重≤3 kg和/或年龄<5天的患者发生并发症的比值比为18.1(3.6 - 91.2;P < 0.001),阴性预测值(NPV)为97%。无论体重如何,年龄>21天的患者风险较低,NPV为96%;无论年龄如何,体重>4 kg的患者NPV为98%。
植入时年龄小和体重低是并发症的危险因素,而设备特征似乎起次要作用。为体重>3 kg且年龄≥5天的患者保留起搏器植入可能预测并发症发生风险低的患者。